Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anika Therapeutics Inc. (ANIK) vs Canopy Growth Corporation (CGC)

Anika Therapeutics Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $397.7M against $270.7M — 1.5× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against 5.33%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −80.4%) and the higher return on invested capital (−3.24% vs −17.2%). Across the 18 metrics below, Anika Therapeutics Inc. leads on 12 and Canopy Growth Corporation on 6.

Valuation

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.25 1.87 2.25
P/B 1.98 0.80 1.90
Price to free cash flow 483.15 n/m 16.54
EV/EBITDA 508.54 n/m 12.29
EV/Sales 2.16 1.52 2.56
Earnings yield (1.28%) (47.27%) (2.99%)
Free cash flow yield 0.21% (15.29%) 0.00%

Profitability

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 25.16% 53.94%
Operating margin (4.24%) (54.89%) 0.00%
Net margin (3.14%) (80.39%) 0.00%
Free cash flow margin 0.47% (28.34%) 0.00%
Return on equity (2.66%) (40.14%) (0.40%)
Return on assets (2.04%) (23.54%) (3.32%)
Return on invested capital (3.24%) (17.19%) 0.00%

Growth

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% 7.80% 10.01%
EPS growth (last fiscal year) 80.16% 84.00% —
Revenue growth, 5-year CAGR (2.86%) (13.04%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.35 0.05
Current ratio 4.48 3.04 2.31
Net debt to EBITDA 10.80 1.09 0.85

Dividend

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ANIK CGC Drug Manufacturers Specialty & Generic median
Market cap 270.74m 397.66m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack